Arunachal youths get lessons in entrepreneurship
Itanagar: In a push to boost entrepreneurship among the youths of Arunachal Pradesh, the industries department has launched a week-long
entrepreneurship development programme
(EDP) in collaboration with the Ahmedabad-based Entrepreneurship Development Institute of India (
EDII
).
The initiative, inaugurated by state industries and skill development minister Nyato Dukam, aims to bridge the gap in professional training and equip aspiring entrepreneurs with the skills needed to launch and sustain successful ventures.
Thirty carefully selected participants from 14 districts of the northeastern state are attending the programme, which covers key areas such as business planning, financial management, marketing strategies, digital tools, and awareness about government schemes.
Addressing the participants, Dukam said entrepreneurship is a vital tool for economic growth.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Standard
29 minutes ago
- Business Standard
Aegis Vopak Terminals slips on debut
Shares of Aegis Vopak Terminals were currently trading at Rs 228.95 at 10:14 IST on the BSE, representing a discount of 2.57% compared with the issue price of Rs 235. The scrip was listed at Rs 220, exhibiting a discount of 6.38% to the issue price. So far, the stock has hit a high of 235.75 and a low of 220. On the BSE, over 6.57 lakh shares of the company were traded in the counter so far. The initial public offer of Aegis Vopak Terminals was subscribed 2.09 times. The issue opened for bidding on 26 May 2025 and it closed on 28 May 2025. The price band of the IPO is fixed between Rs 223 and 235 per share. The offer comprised a fresh issue of up to 119,148,936 equity shares at the upper price band of Rs 235 and 125,560,538 equity shares at the lower price band of Rs 223, aggregating to Rs 2,800 crore. The company will use the IPO proceeds to repay borrowings worth Rs 2,015.95 crore, fund Rs 671.3 crore towards acquiring a cryogenic LPG terminal at Mangalore, and for general corporate purposes. As of 31 March 2025, total borrowings stood at Rs 2,474.17 crore. The Mangalore terminal, with a total capex of Rs 968 crore, is expected to commence operations by June 2025. The project is being developed by Sea Lord Containers, a wholly owned subsidiary of Aegis Logistics and part of the promoter group. Ahead of the IPO, Aegis Vopak Terminals on Friday, 23 May 2025, raised Rs 1,259.99 crore from anchor investors. The board allotted 53,617,021 shares at Rs 235 each to 32 anchor investors. Aegis Vopak Terminals is India's largest third-party tank storage operator for LPG and liquid products, with a total capacity of 1.5 million cubic meters for liquids and 70,800 tonnes for LPG as of 31 December 2024. The company accounts for approximately 11.5% of Indias total LPG static storage capacity and 25.5% of third-party liquid storage capacity. Aegis Vopak is a joint venture between Aegis Logistics (50.1%) and Vopak India BV (47.4%), part of Dutch-based Royal Vopak, a global leader in tank storage with 77 terminals in 23 countries. The company is expanding LPG storage capacity to 200,800 tonnes by FY26 and recently added 101,900 cubic meters of liquid storage at its JNPA terminal in Navi Mumbai. The firm reported a consolidated net profit of Rs 85.8910 crore and total income of Rs 464.18 crore for the nine months ended on 31 December 2024.
Time of India
37 minutes ago
- Time of India
UAE sees surge in foreign-owned real estate firms
More foreign-owned real estate agencies are entering the UAE market as the sector continues to grow in both investment activity and property transactions. With Dubai setting monthly records and other emirates like Ras Al Khaimah attracting first-time investors, the country's property sector is seeing sustained interest from brokers and consultancies, according to a report by Gulf News. The UAE now allows 100% foreign ownership of real estate brokerages, investment consultancies, and development firms. This has become the standard structure for new entrants, according to Jim Swallow, Commercial Director at Sovereign PPG. 'Full foreign ownership in the real estate brokerage, investment consultancy and development is the standard set up now,' he said to Gulf News. 'Most of the demand for a new real estate brokerage business set up is to be 100% foreign-owned.' This shift began in mid-2021, following changes to the UAE's Commercial Companies Law, which removed the previous requirement for a 51% local partner in many mainland sectors, including property services. Since then, new license registrations for real estate firms have increased steadily. While some firms still retain local partnerships—either due to joint ventures or location-specific ownership rules—many have transitioned to full foreign ownership. 'Many firms have since opted for share transfer to 100% foreign ownership if the local partner was a silent partner,' Swallow added. 'Where the local partner was an investor and active in the business, some have opted to be bought out.' (Join our ETNRI WhatsApp channel for all the latest updates) Although Dubai's property price growth is expected to slow in certain areas, interest in setting up brokerages remains strong. New firms are also eyeing opportunities in Ras Al Khaimah and Abu Dhabi, where real estate activity is expanding. Ras Al Khaimah, in particular, is drawing more first-time European investors, prompting overseas consultancies to establish operations there. Live Events You Might Also Like: UAE introduces 5 new categories for Golden Visa eligibility 'There are still foreign family offices and investment firms setting up UAE operations and possibly wanting to take up positions in local real estate,' said a Dubai-based broker to Gulf News. According to the report, in April, Dubai real estate posted its best-ever month for transactions, according to brokers. The Dubai Land Department currently lists over 25,800 licensed real estate brokers, and the number is continuing to rise. This has encouraged fresh graduates to explore careers in real estate, even as agencies like Fitch predict a potential slowdown in price growth in the near term. Becoming a licensed broker in Dubai requires individuals to register with the Dubai Real Estate Institute, complete a training program, and pass an exam administered by the Real Estate Regulatory Agency ( RERA ). A license is issued upon successful completion of the process. As more players enter the market and foreign firms seek to tap into regional demand, the UAE's real estate sector continues to present opportunities despite changing dynamics. You Might Also Like: VFS Global launches world's largest visa centre in Dubai's Wafi
Time of India
37 minutes ago
- Time of India
Sanofi buys US biopharma group Blueprint in $9.1 billion deal
French pharma group Sanofi has agreed to buy US-based Blueprint Medicines Corporation , a biopharmaceutical company specializing in systemic mastocytosis, a rare immunological disease, the companies said on Monday. Under the terms of the acquisition, Sanofi will pay $129.00 per share in cash, representing an equity value of approximately $9.1 billion. The acquisition "represents a strategic step forward in our rare and immunology portfolios. It enhances our pipeline and accelerates our transformation into the world's leading immunology company," said Sanofi CEO Paul Hudson. The deal will add to Sanofi's portfolio the rare immunology disease drug Ayvakit/Ayvakyt (avapritinib), approved in the US and the EU, and a promising advanced and early-stage immunology pipeline . Blueprint's established presence among allergists, dermatologists, and immunologists is also expected to enhance Sanofi's growing immunology pipeline, the companies said. Live Events Ayvakit/Ayvakyt is the only approved medicine for advanced and indolent systemic mastocytosis, a rare immunology disease, which is characterized by the accumulation and activation of aberrant mast cells in bone marrow, skin, the gastrointestinal tract, and other organs. The acquisition will also bring elenestinib, a next-generation medicine for systemic mastocytosis, as well as BLU-808, a highly selective and potent oral wild-type KIT inhibitor that has the potential to treat a broad range of diseases in immunology. Besides $129.00 per share in cash at the closing of the deal, Blueprint shareholders will also receive one non-tradeable contingent value right (CVR) which will entitle the holder to receive two potential milestone payments of $2 and $4 per CVR for the achievement, respectively, of future development and regulatory milestones for BLU-808. The total equity value of the transaction, including potential CVR payments, represents approximately $9.5 billion on a fully diluted basis. Hudson said the deal complements recent acquisitions of other early-stage medicines that remain Sanofi's main field of interest and added that Sanofi still retains a sizeable capacity for further acquisitions.
